MDNAF

Quote

Short

News

Articles

Message Board

Medicenna Therapeutics Corp. (OTCMKTS : MDNAF ) News

Medicenna Therapeutics Corp. (OTCMKTS: MDNAF) News Releases

MDNAF News Releases

June 03, 2026 07:00:00 am

GlobeNewswire

Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

May 28, 2026 09:10:38 am

GlobeNewswire

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

May 22, 2026 07:00:00 am

GlobeNewswire

Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet

May 19, 2026 07:00:00 am

GlobeNewswire

Medicenna Announces the Finalization of the Terms of its Public Offering of Securities

May 13, 2026 04:08:49 pm

SeekingAlpha

Medicenna launches marketed public offering of securities

May 13, 2026 04:01:00 pm

GlobeNewswire

Medicenna Announces the Launch of a Marketed Public Offering of Securities

May 12, 2026 07:00:00 am

GlobeNewswire

Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma

April 30, 2026 07:30:00 am

GlobeNewswire

Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026

April 21, 2026 07:30:00 am

GlobeNewswire

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

April 14, 2026 07:30:00 am

GlobeNewswire

Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account